Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls

• Christian Czech ,

  * E-mail: christian.czech@roche.com

  Affiliation Roche Pharmaceutical Research & Early Development, Neuroscience, Roche Innovation Center Basel F. Hoffmann –La Roche, Basel

  ⨯
• Wakana Tang,

  Affiliation Research - Genomics & Oncology, Roche Molecular Systems, Inc., Pleasanton, CA, United States of America

  ⨯
• Teodorica Bugawan,

  Affiliation Research - Genomics & Oncology, Roche Molecular Systems, Inc., Pleasanton, CA, United States of America

  ⨯
• Calvin Mano,

  Affiliation Research - Genomics & Oncology, Roche Molecular Systems, Inc., Pleasanton, CA, United States of America

  ⨯
• Carsten Horn,

  Affiliation Roche Pharmaceutical Research & Early Development, Neuroscience, Roche Innovation Center Basel F. Hoffmann –La Roche, Basel

  ⨯
• Victor Alejandro Iglesias,

  Affiliation Roche Pharmaceutical Research & Early Development, Neuroscience, Roche Innovation Center Basel F. Hoffmann –La Roche, Basel

  ⨯
• Stefanie Fröhner,

  Affiliation Roche Diagnostics GmbH, Penzberg, Germany

  ⨯
• Phillip G. Zaworski,

  Affiliation PharmOptima Inc., Portage, Michigan, United States of America

  ⨯
• Sergey Paushkin,

  Affiliation SMA Foundation, New York, NY, United States of America

  ⨯
• Karen Chen,

  Affiliation SMA Foundation, New York, NY, United States of America

  ⨯
• Thomas Kremer

  Affiliation Roche Pharmaceutical Research & Early Development, Neuroscience, Roche Innovation Center Basel F. Hoffmann –La Roche, Basel

  ⨯